PRFX Annual EBITDA
-$9.57 M
-$715.00 K-8.08%
31 December 2023
Summary:
As of January 23, 2025, PRFX annual earnings before interest, taxes, depreciation & amortization is -$9.57 million, with the most recent change of -$715.00 thousand (-8.08%) on December 31, 2023. During the last 3 years, it has fallen by -$6.72 million (-236.23%). PRFX annual EBITDA is now -1798.61% below its all-time high of -$504.00 thousand, reached on December 31, 2018.PRFX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRFX Quarterly EBITDA
-$7.34 M
-$1.78 M-32.01%
30 June 2024
Summary:
As of January 23, 2025, PRFX quarterly earnings before interest, taxes, depreciation & amortization is -$7.34 million, with the most recent change of -$1.78 million (-32.01%) on June 30, 2024. Over the past year, it has dropped by -$5.09 million (-226.56%). PRFX quarterly EBITDA is now -1699.26% below its all-time high of -$408.00 thousand, reached on June 30, 2020.PRFX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRFX TTM EBITDA
-$17.81 M
-$5.09 M-40.05%
30 June 2024
Summary:
As of January 23, 2025, PRFX TTM earnings before interest, taxes, depreciation & amortization is -$17.81 million, with the most recent change of -$5.09 million (-40.05%) on June 30, 2024. Over the past year, it has dropped by -$7.81 million (-78.07%). PRFX TTM EBITDA is now -1806.75% below its all-time high of -$934.00 thousand, reached on March 31, 2020.PRFX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRFX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | -226.6% | -78.1% |
| 3 y3 years | -236.2% | -125.9% | -101.1% |
| 5 y5 years | -1798.6% | - | - |
PRFX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | at low | -444.2% | at low | -160.6% | at low |
| 5 y | 5-year | -1198.4% | at low | -1699.3% | at low | -1806.8% | at low |
| alltime | all time | -1798.6% | at low | -1699.3% | at low | -1806.8% | at low |
PainReform EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.34 M(+32.0%) | -$17.81 M(+40.1%) |
| Mar 2024 | - | -$5.56 M(+56.3%) | -$12.72 M(+32.9%) |
| Dec 2023 | -$9.57 M(+8.1%) | -$3.56 M(+163.8%) | -$9.57 M(+3.3%) |
| Sept 2023 | - | -$1.35 M(-40.0%) | -$9.26 M(-7.4%) |
| June 2023 | - | -$2.25 M(-6.9%) | -$10.00 M(+4.2%) |
| Mar 2023 | - | -$2.41 M(-25.7%) | -$9.60 M(+8.4%) |
| Dec 2022 | -$8.85 M(+23.0%) | -$3.25 M(+55.6%) | -$8.85 M(+20.6%) |
| Sept 2022 | - | -$2.09 M(+13.2%) | -$7.34 M(+4.6%) |
| June 2022 | - | -$1.84 M(+10.5%) | -$7.02 M(+2.7%) |
| Mar 2022 | - | -$1.67 M(-3.9%) | -$6.83 M(-5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$7.20 M(+153.0%) | -$1.74 M(-1.6%) | -$7.20 M(+15.3%) |
| Sept 2021 | - | -$1.77 M(+6.4%) | -$6.24 M(+20.1%) |
| June 2021 | - | -$1.66 M(-18.6%) | -$5.20 M(+31.7%) |
| Mar 2021 | - | -$2.04 M(+160.9%) | -$3.95 M(+38.8%) |
| Dec 2020 | -$2.85 M(+286.2%) | -$781.00 K(+8.0%) | -$2.85 M(+37.8%) |
| Sept 2020 | - | -$723.00 K(+77.2%) | -$2.06 M(+53.9%) |
| June 2020 | - | -$408.00 K(-56.3%) | -$1.34 M(+43.7%) |
| Mar 2020 | - | -$934.00 K | -$934.00 K |
| Dec 2019 | -$737.00 K(+46.2%) | - | - |
| Dec 2018 | -$504.00 K | - | - |
FAQ
- What is PainReform annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for PainReform?
- What is PainReform annual EBITDA year-on-year change?
- What is PainReform quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for PainReform?
- What is PainReform quarterly EBITDA year-on-year change?
- What is PainReform TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for PainReform?
- What is PainReform TTM EBITDA year-on-year change?
What is PainReform annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRFX is -$9.57 M
What is the all time high annual EBITDA for PainReform?
PainReform all-time high annual earnings before interest, taxes, depreciation & amortization is -$504.00 K
What is PainReform annual EBITDA year-on-year change?
Over the past year, PRFX annual earnings before interest, taxes, depreciation & amortization has changed by -$715.00 K (-8.08%)
What is PainReform quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRFX is -$7.34 M
What is the all time high quarterly EBITDA for PainReform?
PainReform all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$408.00 K
What is PainReform quarterly EBITDA year-on-year change?
Over the past year, PRFX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.09 M (-226.56%)
What is PainReform TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRFX is -$17.81 M
What is the all time high TTM EBITDA for PainReform?
PainReform all-time high TTM earnings before interest, taxes, depreciation & amortization is -$934.00 K
What is PainReform TTM EBITDA year-on-year change?
Over the past year, PRFX TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.81 M (-78.07%)